Vizag Pharmaceuticals Private Limited

Vizag Pharmaceuticals Private Limited

Produces drugs and pharmaceuticals.
2003 | Hyderabad, Telangana (India) | Active

Last Updated:

July 05, 2024
HomeCompanyVizag Pharmaceuticals Private Limited

Who are the key members and board of directors at Vizag Pharmaceuticals?

Board Members(2)

NameDesignationAppointment DateStatus
Sunil Annapu In Director 28-Apr-2003Current
Burri Kumar In Director 28-Apr-2003Current

Financial Performance of Vizag Pharmaceuticals.

Vizag Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 52.33% decrease. The company also saw a substantial fall in profitability, with a 39.71% decrease in profit. The company's net worth moved up by a moderate rise of 3.32%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-52.33%
Revenue from Operations
-55.11%
Total Assets
49.09%
Profit or Loss
-39.71%
Net Worth
3.32%
EBITDA
-56.77%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹3.50 M

LenderAmountStatus

Idbi Bank Limited

Creation Date: 02 Nov 2010
₹3.50 MOpen

How Many Employees Work at Vizag Pharmaceuticals?

Unlock and access historical data on people associated with Vizag Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Vizag Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Vizag Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.

    30 Sep 2016

  • Balance Sheet

    Vizag Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad.

    31 Mar 2016

  • Charges

    A charge with Idbi Bank Limited of Rs. 3.50 M registered on 02 Nov 2010 with Charge ID 10256321 was modified on 05 Feb 2013.

    05 Feb 2013

  • Charges

    A charge with Idbi Bank Limited amounted to Rs. 3.50 M with Charge ID 10256321 was registered on 02 Nov 2010.

    02 Nov 2010

  • Director Appointment

    Sunil Kumar Annapu was appointed as a Director was appointed as a Director on 28 Apr 2003 & has been associated with this company since 21 years 7 months .

    28 Apr 2003

  • Director Appointment

    Burri Vijaya Kumar was appointed as a Director was appointed as a Director on 28 Apr 2003 & has been associated with this company since 21 years 7 months .

    28 Apr 2003

Frequently asked questions

  • Vizag Pharmaceuticals Private Limited was incorporated on 28 Apr 2003.

  • The authorized share capital of Vizag Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 1.10 M.

  • Currently 2 directors are associated with Vizag Pharmaceuticals Private Limited.

    • Sunil Kumar Annapu
    • Burri Vijaya Kumar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Vizag Pharmaceuticals Private Limited is #401/A Abhis Hiranya Guttala, Begumpet Madhapur, Hyderabad, Telangana, India, 500081.

  • The corporate identification number (CIN) of Vizag Pharmaceuticals Private Limited is U24239TG2003PTC040903 and the company number is 040903 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2016, the revenue trend for Vizag Pharmaceuticals Private Limited has fallen by -52.33%.

  • The financial reports for the fiscal year 2016 indicates that The net worth of Vizag Pharmaceuticals Private Limited has experienced an upsurge of 3.32%.

  • As per the financial statements for fiscal Year 2016, The total open charges for Vizag Pharmaceuticals Private Limited amount to ₹ 3.50 M.

  • The most recent Balance Sheet for Vizag Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2016.

People also Viewed

Similar Companies Based on Drug Formulation & Development